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♦ Background: Reduced free water transport (FWT) through 
ultrasmall pores contributes to net ultrafiltration failure 
(UFF) and should be seen as a sign of more severe functional 
deterioration of the peritoneal membrane. The modified 
peritoneal equilibration test (PET), measuring the dip in 
dialysate Na concentration, estimates only FWT. Our aim 
was to simultaneously quantify small-solute transport, 
FWT, and small-pore ultrafiltration (SPUF) during a single 
PET procedure.
♦ Methods: We performed a 4-hour, 3.86% glucose PET, 
with additional measurement of ultrafiltration (UF) at 
60 minutes, in 70 peritoneal dialysis patients (mean age: 
50 ± 16 years; 61% women; PD vintage: 26 ± 23 months). 
We calculated the dialysate-to-plasma ratios (D/P) of 
creatinine and Na at 0 and 60 minutes, and the Na dip 
(DipD/PNa60′), the delta dialysate Na 0–60 (ΔDNa0–60), FWT, 
and SPUF.
♦ Results: Sodium sieving (as measured by ΔDNa0–60) cor-
related strongly with the corrected DipD/PNa60′ (r = 0.85, p < 
0.0001) and the corrected FWT (r = 0.41, p = 0.005). Total 
UF showed better correlation with FWT than with indirect 
measurements of Na sieving (r = 0.46, p < 0.0001 for FWT; 
r = 0.360, p < 0.0001 for DipD/PNa60′). Corrected FWT frac-
tion was 0.45 ± 0.16. A negative correlation was found 
between time on PD and both total UF and FWT (r = –0.253, 
p = 0.035 and r = –0.272, p = 0.023 respectively). The 11 
patients (15.7%) diagnosed with UFF had lower FWT (89 mL 
vs 164 mL, p < 0.05) and higher D/P creatinine (0.75 vs 
0.70, p < 0.05) than did the group with normal UF. The SPUF 
correlated positively with FWT in the normal UF group, but 
negatively in UFF patients (r = –0.709, p = 0.015). Among 
UFF patients on PD for a longer period, 44.4% had a FWT 
percentage below 45%.
♦ Conclusions: Measurement of FWT and SPUF is fea-
sible by simultaneous quantification during a modified 
3.86% glucose PET, and FWT is a decisive parameter for 
detecting causes of UFF in addition to increased effective 
capillary surface.
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Ultrafiltration failure (UFF) is an important cause of treatment drop-out in long-term peritoneal dialysis 
(PD). Heimbürger et al. (1) reported a cumulative risk for 
the development of permanent loss of net ultrafiltration 
(UF) of 3% after 1 year and 31% after 6 years of PD treat-
ment. At that time, UF loss was associated mostly with a 
large effective peritoneal surface area (1–3) or, eventu-
ally, with a high lymphatic absorption rate (1).
Later, once aquaporins in the capillary peritoneal wall 
were demonstrated, some authors showed that impaired 
water transport through the ultrasmall pores could con-
tribute to net UFF in PD (4,5). That finding was based on 
an observed reduction of sodium sieving during a 3.86% 
glucose peritoneal equilibration test (“modified PET”). 
In the first hour of a modified PET, a strong osmotic gra-
dient over the aquaporins induces free water transport 
(FWT) from the capillaries to the dialysate, resulting in 
a decrease (by dilution) of the dialysate sodium concen-
tration. This dip in dialysate sodium is hence an indirect 
method for estimating the magnitude of water transport 
through the ultrasmall pores. However, it is important to 
bear in mind that an apparent reduction in sodium sieving 
can also be caused by increases in peritoneal small-solute 
diffusion, or by a reduction in the UF coefficient (LpS) of 
the peritoneal membrane (6,7). Therefore, a reliable tool 
to quantify both peritoneal FWT and small-pore solute and 
fluid transport would be of great practical importance.
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Recently, two methods—one by La Milia et al. (“mini-
PET”) (8), and the other by Smit et al. (9)—have been 
developed to assess aquaporin-mediated water transport 
in PD patients. These methods have both been validated 
by computer simulations using the three-pore model of 
peritoneal transport (10). Compared with the method 
from Smit et al., the mini-PET is simple because it does 
not involve sophisticated calculations or measurement 
of fluid absorption by calculation of the clearance of a 
macromolecular marker. Although extremely accurate 
in measuring FWT, the mini-PET does not reproduce the 
standardized small-solute transport categorization, be-
cause its dialysate-to-plasma ratio of creatinine (D/P Cr) 
measured at 60 minutes of the dwell reveals a relatively 
higher rate of small-solute transport than is found in a 
4-hour dwell (11). Besides, it is burdensome in clinical 
practice to have each patient undergo different types of 
PET for an evaluation of membrane status. To overcome 
this limitation, Cnossen et al. (12) performed a study in 
which they compared, in 10 prevalent PD patients, small-
solute transport assessed in a 4-hour, 3.86% glucose 
PET, with temporary drainage after 1 hour (allowing for 
quantification of FWT), concluding that the interim step 
did not influence the D/P Cr result. Because no further 
report has yet re-evaluated the clinical relevance of their 
approach, we aimed to extend our present investigation 
into diagnosing UFF in a larger population by simultane-
ously evaluating small-solute transport and more ac-
curately assessing ultrasmall- and small-pore UF using 
a single PET procedure.
METHODS
PATIENTS AND PROCEDURES
This cross-sectional study enrolled 70 patients (29 
men, 41 women; mean age: 50 ± 16 years) attending PD 
units at Hospital Geral de Santo António – Centro Hos-
pitalar do Porto, Portugal, and Hospital Universitario 
La Paz, Spain, between January 2008 and August 2010. 
Mean time on PD was 26 months (range: 1 – 121 months). 
Of the 70 patients, 43 (61%) were on automated PD. 
None of the patients had peritonitis during the study 
or the preceding 4 weeks. The test was performed as a 
routine annual evaluation of membrane status without 
elective selection.
A 4-hour 3.86% glucose modified PET with tempo-
rary drainage at 60 minutes (13) was performed in all 
patients. During the procedure, we used PD solutions 
low in glucose degradation products [either Balance 
(Fresenius Medical Care, Bad Homburg, Germany) or 
Physioneal (Baxter Healthcare Corporation, Deerfield, 
IL, USA) according to the individual patient’s prescrip-
tion]. The volume of dialysis solution was determined 
by weight, without flushing the system and before fill-
ing the peritoneum. Blood and dialysate samples (each 
approximately 10 mL) were taken at instillation of the 
dialysate and after 60 and 240 minutes. At 60 minutes, 
we performed an additional measurement of UF by total 
drainage of the peritoneal cavity. This drained volume 
was weighed and then immediately reinfused. Finally, 
after 240 minutes, the peritoneal cavity was drained and 
the drained volume was weighed.
A PET with an ultrafiltrate volume of 400 mL or less 
at 4 hours was considered to represent UFF. By that 
definition, UFF was detected in 11 patients (15.7%), 
who were analyzed separately and compared with the 
stable group.
MEASUREMENTS
Creatinine and sodium were measured in both plasma 
and dialysate. Glucose was assessed in dialysate. 
Creatinine and glucose were measured using standard 
automated analyzer techniques. For creatinine, the 
Jaffé compensated method was used. The dialysate 
creatinine concentration was corrected for interference 
by glucose according to laboratory standards. Sodium in 
dialysate and plasma was measured using indirect ion- 
selective electrodes.
CALCULATIONS
We calculated the dialysate-to-plasma sodium (D/PNa) 
at the beginning (D/PNa0′) and at 1 hour (D/PNa60′) of the 
study PET. The Dip_D/PNa60′ is the difference between 
the D/PNa0′ and the D/PNa60′. The mass transfer area 
coefficient for creatinine (MTAC Cr), calculated by the 
simplified Garred model (14,15), was used to estimate the 
dialysate sodium concentration attributable to diffusion 
(16,17). The resulting value was then subtracted from 
the sodium concentration measured in the dialysate at 
60 minutes. Thus, we were able to calculate the D/PNa60′ 
and the respective Dip_D/PNa60′, with and without cor-
rection for sodium diffusion, according to previous 
methods used to assess unit reference values (11). As 
a more simple clinical tool, the difference in dialysate 
sodium (ΔDNa0–60′) was also measured by subtracting the 
dialysate sodium at 60 minutes (DNa60′) from the initial 
dialysate sodium (DNa0′) (13).
During the study PET, FWT was calculated as follows:
FWT (mL) = Total UF volume at 60 minutes (mL) – UF
through the small pores at 60 minutes (mL).
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The UF through the small pores (SPUF) at 60 minutes 
was calculated as follows:
SPUF (mL) = [NaR (mmol) × 1000] / PNa,
where NaR (mmol) is sodium removal and PNa is the 
sodium concentration in plasma assessed by indirect 
ion-selective electrodes. The NaR was calculated as
[Dialysate V at 60 minutes (L) × Dialysate Na at
60 minutes (mmol/L)] – [Dialysate V instilled 
(L) × Dialysate Na at 0 minutes (mmol/L)].
Using a simple algorithm, we also performed a correc-
tion for FWT as described by Venturoli and Rippe (10):
FWTcorrected = 
Total UF at 60 minutes + 15 – 0.92 × SPUF,
where the “15” represents cumulative lymphatic absorp-
tion during 60 minutes (18 mL) minus the cumulative 
UF through the large pores during 60 minutes (approxi-
mately 3 mL). The FWT fraction was also evaluated.
In addition, patients were characterized by peritoneal 
transport status as described by Twardowski et al. (18).
STATISTICAL ANALYSIS
Data with normal distribution are expressed as mean 
± 1 standard deviation, with 95% confidence intervals. 
Asymmetrically distributed data are reported as medians 
and interquartile ranges.
Pearson and Spearman correlation analyses were used, 
as appropriate, to investigate possible relations between 
the parameters of peritoneal transport.
Comparisons of the parameters of peritoneal transport 
between patients on PD for less than 2 years and for 2 or 
more years were performed using the Student t-test or Mann–
Whitney U-test (according to the variables involved).
We also used the unpaired Student t-test or Mann-
Whitney U-test to compare patients with and without 
UFF according to the variables involved.
Values of p less than 0.05 were considered statistically 
significant. Statistical analyses were performed using the 
SPSS software application (version 15.0: SPSS, Chicago, 
IL, USA) for Windows.
RESULTS
SOLUTE AND FLUID TRANSPORT PARAMETERS
Table 1 summarizes the peritoneal transport char-
acteristics from the PET performed in the 70 study 
patients. Notably, FWT accounted for 35.8% of the UF at 
60 minutes, and once corrected (for sodium  diffusion, 
 cumulative UF volume through the large pores, and 
cumulative lymphatic absorption at 60 minutes), its 
contribution increased to a mean of 45.3%. With respect 
to small-solute transport characteristics, 2 patients (3%) 
were categorized as slow transporters (D/P Cr ≤ 0.49), 19 
(27%) as slow-average (0.50 ≤ D/P Cr ≤ 0.64), 42 (60%) 
as fast-average (0.65 ≤ D/P Cr ≤ 0.80), and 7 (10%) as 
fast transporters (D/P Cr ≥ 0.81).
CORRELATIONS BETWEEN TOTAL UF, SODIUM SIEVING, AND 
FWT QUANTIFICATION
Total UF at 4 hours showed a better correlation with 
quantified FWT than with any indirect measurement of 
sodium sieving (r = 0.46, p < 0.0001 for FWT; r = 0.48, p < 
0.0001 for FWTcorrected; r = –0,29, p < 0.0001 for D/PNa60′; 
r = –0.45, p < 0.0001 for D/PNa60′corrected; r = 0.36, p < 
0.0001 for Dip_D/PNa60′; r = 0.44, p < 0.0001 for Dip_D/
PNa60′corrected; and r = 0.32, p = 0.005 for ΔDNa0–60′).
TABLE 1 
Peritoneal Transport Characteristics in 70 Stable 
 Patients Assessed During a 4-Hour, 3.86%  
Glucose Peritoneal Equilibration Test with  
Temporary Drainage at 60 Minutes
 Value
 Variable Mean±SD 95% CI
Total UF at 4 h (mL) 665.73 ± 235.39 609.60 to 721.85
UF at 1 h (mL) 425.25 ± 21.74 381.87 to 468.63
SPUF (mL) 274.03 ± 133.32 240.28 to 304.45
FWT (mL) 152.14 ± 88.51 131.52 to 174.25
FWTcorrected (mL) 189.03 ± 92.09 167.39 to 211.89
%FWT 35.79 ± 17.59 31.8 to 40.24
%FWTcorrected (mL) 45.34 ± 16.58 41.39 to 49.29
MTAC Cr (mL/min) 9.15 ± 4.11 8.13 to 10.11
D/P Cr 0.70 ± 0.10 0.68 to 0.73
D240/D0 glucose 0.35 ± 0.15 0.32 to 0.39
D/PNa60′	 0.89 ± 0.04 0.88 to 0.91
D/PNa60′corrected 0.84 ± 0.06 0.82 to 0.86
Dip_D/PNa60′	 0.04 ± 0.02 0.03 to 0.04
Dip_D/PNa60′corrected 0.10 ± 0.05 0.09 to 0.11
SD = standard deviation; CI = confidence interval; UF = ultra-
filtration; SPUF = UF through the small pores at 60 minutes; 
FWT = free water transport at 60 minutes; FWTcorrected = FWT 
with an algorithm correction according to Venturoli et al. 
(10); MTAC = mass transfer-area coefficient; Cr = creatinine; 
D/P = dialysate-to-plasma ratio; D240/D0 = end (240 min)–to–
initial dialysate ratio; D/PNa60′ = D/P sodium at 60 minutes; 
D/PNa60′corrected = D/P sodium at 60 minutes corrected for diffu-
sion; Dip_D/PNa60′ = difference between initial and 60-minute 
D/P sodium; Dip_D/PNa60′corrected = difference between initial 
and 60-minute D/P Na, corrected for diffusion.
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We found a significant correlation between sodium 
sieving measurements and FWT quantification, especially 
when FWT was corrected for diffusion [Figure 1(A,B)]. 
Additionally, a simple tool such as ΔDNa0–60′ correlated 
strongly with the corrected dip [r = 0.85, p < 0.0001, 
Figure 1(C)] and with FWT (r = 0.41, p < 0.0001), which 
is relevant for routine bedside evaluation.
SHORT- COMPARED WITH LONG-TERM PD TREATMENT
Of the study patients, 41 (59%) had been on PD for 
fewer than 2 years (short-term PD), and 29 patients 
(41%) had been on PD for 2 or more years (long-term 
PD). Although none of the comparisons were statisti-
cally significant, the long-term group had lower FWT and 
total UF values (data not shown). However, we observed 
a statistically significant trend to achieve less total UF 
and less FWT over time on PD [Figure 2(A,B)].
UFF AND WATER TRANSPORT PATHWAYS
Among the 70 study patients, 11 (15.7%) had UFF 
(total UF ≤ 400 mL). Although the difference was not sta-
tistically significant, patients with normal UF had been 
on PD treatment for a shorter period of time (Table 2). 
Compared with stable patients, patients with UFF had 
a significantly lower mean FWT, a higher D/P Cr, and a 
higher MTAC Cr (Table 2). Among 9 patients with UFF 
who had been on PD for more than 18 months (82%), 2 
(22.2%) were fast transporters, and 4 (44.4%) had a FWT 
percentage corrected for sodium diffusion of less than 
45% (the mean for the entire population). Notably, as 
Figure 3 shows, SPUF correlated positively with FWT in the 
non-UFF group (r = 0.257, p = 0.032), but more strongly and 
negatively in the UFF group (r = –0.709, p = 0.015).
DISCUSSION
To our knowledge, the present study is the first to 
report simultaneous small-pore and ultrasmall-pore 
peritoneal transport quantification in a large PD popula-
tion through the use of a 4-hour 3.86% glucose PET with 
temporary drainage at 60 minutes. The UF quantification 
at 60 minutes allows for FWT to be measured as first de-
scribed by La Milia and colleagues (8). Our study expands 
the work of the La Milia group, because the 4-hour PET 
with the added procedure allows for both FWT and small-
pore UF to be measured at the same time that peritoneal 
solute transport is being quantified in a standardized 
way, without the overestimation that might occur when 
transport categorization is based on a D/P Cr obtained 
after a 60-minute dwell (11).
Figure 1 — Correlations between (A) the dialysate-to-plasma 
(D/P) sodium at 60 minutes corrected for diffusion (D/
PNa60′corrected) and free water transport with an algorithm cor-
rection (FWTcorrected) according to Venturoli and Rippe (10) 
(Pearson r = –0.80, p < 0.0001); (B) the difference (“delta”) of 
the initial D/P sodium (D/PNa0′) and the 60-minute D/P sodium 
corrected for diffusion (Dip_D/PNa60′corrected) and FWTcorrected 
according to Venturoli and Rippe (10) (Pearson r = 0.68, p < 
0.0001); and (C) the corrected dip and delta sodium (Pearson 
r = 0.85, p < 0.0001).
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Even when no correction was made for sodium diffu-
sion, the results obtained for FWT (mean FWT at 60 min-
utes: 152 mL) were quite similar to those obtained with 
a more accurate and sophisticated method that used a 
volume marker [mean FWT at 60 minutes: 135 mL accord-
ing to Smit et al. (9); median FWT at 60 minutes: 154 mL 
according to Parikova et al. (19)]. We also emphasize 
that the results obtained regarding the contribution of 
FWT to 60-minute UF are in line with those reported by 
La Milia—mean FWTcorrected being 45% in our study, and 
mean FWT percentage being 46% in the report by La 
Milia et al. (8). Also, skilled studies from Waniewski et 
al., whatever the adjustments and methodology used, 
found a FWT fraction of 0.40 ± 0.12, which is equivalent 
to the fraction that we documented (20,21).
The fact that FWT correlates better with total UF than 
with any indirect measure of sodium sieving is evidence 
that reduced water flow through aquaporins is some-
how not the only factor connected with reduced sodium 
sieving (7). As expected, the algorithm correction for 
sodium diffusion that we used allowed us to correct 
some underestimation of FWT because of the presence 
of sodium diffusion from the circulation (10). To cor-
rect the calculations for diffusive sodium transport, the 
MTAC Cr estimated using the simplified Garred formula 
[following the methodology previously published by the 
Krediet group (16)], was also used by Asghar and Davies 
(22) to investigate peritoneal fluid pathways. Although 
the simplified Garred model may be less accurate than 
the Waniewski model, the good correlation between 
these two models allows for the use of the former model 
in routine clinical evaluation (11). However, we suggest 
that peritoneal transport quantification can rely on a 
two-in-one protocol of 4-hour PET that simultaneously 
provides information on D/P creatinine (at 4 hours) and 
60-minute FWT quantification, avoiding correction for-
mulas and indirect estimates of sodium sieving that have 
been found to be less discriminative.
We also found a slight, but consistent, tendency for 
FWT to decline with time on PD. Such impairment might 
occur as a consequence of interstitial membrane changes, 
lowering the capacity of glucose to exert its osmotic ef-
fect on the ultrasmall pores. To explain the apparently 
“paradoxical” observation that, although FWT was lower 
in patients with UFF than in those without UFF, the FWT 
percentage simultaneously failed to reach statistical 
significance when those groups were compared, it must 
be emphasized that the decrease in aquaporin function 
indeed cannot be cited as the single reason for the FWT 
decrease. Because of dissipation of the glucose osmotic 
gradient, FWT depends on and is inversely correlated with 
increased MTAC Cr—the more common cause of UFF. Our 
results accord with those of Parikova et al. (23): that is, 
by analyzing fluid transport pathways and their determi-
nants in patients with UFF, documented early-stage UFF is 
Figure 2 — Simultaneous small-pore and ultrasmall-pore peri-
toneal transport evaluation and its profile with time on perito-
neal dialysis (PD). Correlations between (A) total ultrafiltration 
(UF240′) and time on PD (Pearson r = –0.272, p = 0.023); (B) free 
water transport with an algorithm correction (FWTcorrected) ac-
cording to Venturoli and Rippe (10) and time on PD (Pearson r = 
–0.253, p = 0.035); and (C) small-pore ultrafiltration (SPUF) 
with time on PD (Pearson r = –0.243 p = 0.003).
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associated with a decline in FWT dependent on increased 
effective capillary surface area without significant de-
crease of FWT contribution. Later, aquaporin dysfunction 
and additional interstitial changes combine to cause a 
significant decline in the FWT fraction with loss of glu-
cose osmotic conductance. Interestingly, we found that 
TABLE 2 
Simultaneous Small-Pore and Ultrasmall-Pore Peritoneal Transport Evaluation for Peritoneal Dialysis (PD) Patients 
With and Without Ultrafiltration (UF) Failure
 Ultrafiltration failure
 Patients without Patients with
 Mean±SD 95% CL Mean±SD 95% CL
Patients (n)  59   11
Time on PD (months) 23.43±21.65 17.79, 29.08 38.15±28.25 19.17, 57.14
Total UF at 4 h (mL) 732.40±188.78a 683.19, 781.59 308.18±93.68a 245.25, 371.12
UF at 1 h (mL) 453.25±179.89a 406.37, 500.13 280.91±83.27a 224.97, 336.85
SPUF (mL) 289.43±136.50b 253.86, 325.00 191.44±75.39b 140.79, 242.08
FWT (mL) 163.83±87.03b 141.14, 186.51 89.47±70.69b 41.98, 136.96
FWTcorrected (mL) 201.96±90.50
c 178.37, 225.54 119.73±68.85c 73.47, 165.98
%FWT 36.96±16.29 32.71, 41.20 29.53±23.33 13.86, 45.20
%FWTcorrected (mL) 46.17±15.79 42.06, 50.29 40.88±20.59 27.04, 54.71
MTAC Cr (mL/min) 8.74±4.07b 7.68, 9.80 11.38±3.70b 8.90, 13.87
D/P Cr 0.70±0.10b 0.67, 0.72 0.75±0.07b 0.70, 0.80
D240/D0 glucose 0.37±0.16 0.33, 0.41 0.27±0.03 0.25, 0.30
D/PNa60′	 0.90±0.04
b 0.89, 0.90 0.93±0.04b 0.90, 0.95
D/PNa60′corrected 0.83±0.06
b 0.81, 0.85 0.89±0.07b 0.85, 0.94
Dip_D/PNa60′	 0.04±0.02 0.03, 0.05 0.03±0.02 0.02, 0.05
Dip_D/PNa60′corrected 0.11±0.04
b 0.10, 0.12 0.06±0.05b 0.03, 0.09
SD = standard deviation; CL = confidence limits; SPUF = UF through the small pores at 60 minutes; FWT = free water transport at 
60 minutes; FWTcorrected = FWT with an algorithm correction according to Venturoli and Rippe (10); MTAC = mass transfer-area coef-
ficient; Cr = creatinine; D/P = dialysate-to-plasma ratio; D240/D0 = end (240 min)–to–initial dialysate ratio; D/PNa60′ = D/P sodium 
at 60 minutes; D/PNa60′corrected = D/P sodium at 60 minutes corrected for diffusion; Dip_D/PNa60′ = difference between initial and 
60-minute D/P sodium; Dip_D/PNa60′corrected = difference between initial and 60-minute D/P Na, corrected for diffusion.
a t-Test p < 0.0001, comparing patients with and without ultrafiltration failure.
b t-Test p < 0.05, comparing patients with and without ultrafiltration failure.
c t-Test p < 0.005, comparing patients with and without ultrafiltration failure.
Figure 3 — Small-pore and ultrasmall-pore peritoneal water transport pathways. (A) Free water transport (FWT) and small-pore 
water transport both contribute to net ultrafiltration in patients without ultrafiltration failure (r = 0.257, p = 0.032). (B) Dispro-
portionate decline in FWT in patients with ultrafiltration failure (r = –0.709, p = 0.015).
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small-pore and aquaporin water transport both positively 
correlate in non-UFF patients; however, in acquired UFF, 
a disproportionate profile was documented, suggesting 
that ultrasmall-pore transport indeed depends on other 
than the effective capillary surface. Interstitial fibrosis 
may explain this “uncoupling” between changes in small-
pore transport and in FWT that we observed in patients 
with UFF (24).
Hence, our procedure allows for an exploration of 
various time-dependent changes of the ultrasmall- and 
small-pore water transport pathways. It also enables the 
identification of causes of UFF in our population, with 
important repercussions for PD prescription. Among the 
11 patients with UFF, 5 had a FWTcorrected contribution 
to UF at 60 minutes that was less than 45%, and only 2 
of those 5 were categorized as fast transporters. That 
finding suggests again a higher compromise of FWT, 
disproportionate to higher small-solute transport. This 
understanding is of particular importance from a clinical 
viewpoint, because these patients will benefit most from 
icodextrin instead of hypertonic glucose prescriptions. 
Extension of the two-in-one protocol (5-hour “uni-PET”) 
or performance of a double mini-PET (25) to measure 
glucose osmotic conductance as a second evaluation step 
could aid in the diagnosis of UFF. However, we skipped 
such tests because we already adopt icodextrin prescrip-
tion whenever a patient presents increased effective 
capillary surface or reduced FWT, abolishing the use of 
hypertonic 3.86% solutions in regular prescriptions.
One of the limitations of our study is the inability to 
quantify the lymphatic absorption rate, which is not 
feasible day-to-day in the clinic, and whose methodol-
ogy is still under debate (26). It is a known simplifica-
tion of the three-pore model to assume that absorption 
of fluid from the peritoneal cavity is constant, at a rate 
of 0.3 mL per minute. In fact, peritoneal fluid absorp-
tion varies between patients and might even be a cause 
of UFF, but peritoneal absorption remains a difficult 
problem for investigators, and no clinical procedure is 
able to exclude peritoneal absorption except by using a 
macromolecular tracer such as dextran (19) or radioio-
dinated human serum albumin (27,28). However, high 
lymphatic absorption is recognized to be mostly a cause 
of inherent UFF and, more rarely, a cause of acquired UFF 
(23,29). The fact that UFF presented mostly in our pa-
tients with longer time on PD may counteract the effect of 
this limitation.
CONCLUSIONS
Quantification of FWT is important for detecting causes 
of UFF beyond increased effective capillary surface. Such 
quantification is feasible during a routine 4-hour 3.86% 
PET evaluation with temporary drainage at 60 minutes. 
This two-in-one protocol provides reliable and use-
ful clinical information concerning both small-solute 
transport and the various water transport pathways. 
Furthermore, complicated calculations needed to correct 
for sodium diffusion are avoided, allowing the test to 
be easily applied in daily clinical practice. The proposed 
two-in-one protocol, documenting the most common 
peritoneal membrane dysfunctions and giving prognostic 
information, is a simple method for timely detection of 
membrane failure. We therefore advocate using this PET 
evaluation in routine annual PD patient management so 
that therapy can be properly adjusted.
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